Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, Status and Forecast 2023-2027

Report ID: 888105 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Allogeneic CAR T-Cells
        1.2.3 Autologous CAR T-Cells
    1.3 Market by Application
        1.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Diagnostic Center
        1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
    2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Perspective (2016-2027)
    2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Growth Trends by Regions
        2.2.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Share by Regions (2016-2021)
        2.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027)
    2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Dynamic
        2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends
        2.3.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
        2.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges
        2.3.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue
        3.1.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue (2016-2021)
        3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2016-2021)
    3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue
    3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio
        3.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2020
    3.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Area Served
    3.6 Key Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Solution and Service
    3.7 Date of Enter into Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Type
    4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Type (2016-2021)
    4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)

5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Application
    5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Application (2016-2021)
    5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
    6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
        6.2.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
        6.2.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
        6.2.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
    6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
        6.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
        6.3.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
        6.3.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
    6.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        6.4.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
        6.4.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
    7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
        7.2.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
        7.2.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
        7.2.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
    7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
        7.3.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
        7.3.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
        7.3.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
    7.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        7.4.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
        7.4.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
    8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
        8.2.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
        8.3.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
        8.4.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
    9.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
        9.2.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
        9.2.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
        9.2.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
    9.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
        9.3.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
        9.3.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
        9.3.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
    9.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        9.4.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
        9.4.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
    10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
        10.2.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
        10.3.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
        10.4.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.1.4 Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.2.4 Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Bristol Myers Squibb
        11.3.1 Bristol Myers Squibb Company Details
        11.3.2 Bristol Myers Squibb Business Overview
        11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.3.4 Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.3.5 Bristol Myers Squibb Recent Development
    11.4 Legend Biotech
        11.4.1 Legend Biotech Company Details
        11.4.2 Legend Biotech Business Overview
        11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.4.4 Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.4.5 Legend Biotech Recent Development
    11.5 Sorrento Therapeutics
        11.5.1 Sorrento Therapeutics Company Details
        11.5.2 Sorrento Therapeutics Business Overview
        11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.5.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.5.5 Sorrento Therapeutics Recent Development
    11.6 CARSGEN Therapeutics，Ltd
        11.6.1 CARSGEN Therapeutics，Ltd Company Details
        11.6.2 CARSGEN Therapeutics，Ltd Business Overview
        11.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.6.4 CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.6.5 CARSGEN Therapeutics，Ltd Recent Development
    11.7 Juno Therapeutics
        11.7.1 Juno Therapeutics Company Details
        11.7.2 Juno Therapeutics Business Overview
        11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.7.4 Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.7.5 Juno Therapeutics Recent Development
    11.8 Kite Pharma
        11.8.1 Kite Pharma Company Details
        11.8.2 Kite Pharma Business Overview
        11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.8.4 Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.8.5 Kite Pharma Recent Development
    11.9 Atara Biotherapeutics
        11.9.1 Atara Biotherapeutics Company Details
        11.9.2 Atara Biotherapeutics Business Overview
        11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.9.4 Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.9.5 Atara Biotherapeutics Recent Development
    11.10 Carina Biotech
        11.10.1 Carina Biotech Company Details
        11.10.2 Carina Biotech Business Overview
        11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.10.4 Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.10.5 Carina Biotech Recent Development
    11.11 Guangzhou Xiangxue Pharmaceutical
        11.11.1 Guangzhou Xiangxue Pharmaceutical Company Details
        11.11.2 Guangzhou Xiangxue Pharmaceutical Business Overview
        11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
        11.11.4 Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
        11.11.5 Guangzhou Xiangxue Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Allogeneic CAR T-Cells
    Table 3. Key Players of Autologous CAR T-Cells
    Table 4. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Regions (2016-2021)
    Table 8. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Regions (2022-2027)
    Table 10. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends
    Table 11. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
    Table 12. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges
    Table 13. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints
    Table 14. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Players (2016-2021)
    Table 16. Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy as of 2020)
    Table 17. Ranking of Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Solution and Service
    Table 21. Date of Enter into Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
    Table 25. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
    Table 29. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Pfizer Company Details
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 64. Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 65. Pfizer Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 69. Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Bristol Myers Squibb Company Details
    Table 72. Bristol Myers Squibb Business Overview
    Table 73. Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 74. Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 75. Bristol Myers Squibb Recent Development
    Table 76. Legend Biotech Company Details
    Table 77. Legend Biotech Business Overview
    Table 78. Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 79. Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 80. Legend Biotech Recent Development
    Table 81. Sorrento Therapeutics Company Details
    Table 82. Sorrento Therapeutics Business Overview
    Table 83. Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 84. Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 85. Sorrento Therapeutics Recent Development
    Table 86. CARSGEN Therapeutics，Ltd Company Details
    Table 87. CARSGEN Therapeutics，Ltd Business Overview
    Table 88. CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 89. CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 90. CARSGEN Therapeutics，Ltd Recent Development
    Table 91. Juno Therapeutics Company Details
    Table 92. Juno Therapeutics Business Overview
    Table 93. Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 94. Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 95. Juno Therapeutics Recent Development
    Table 96. Kite Pharma Company Details
    Table 97. Kite Pharma Business Overview
    Table 98. Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 99. Kite Pharma Recent Development
    Table 100. Atara Biotherapeutics Company Details
    Table 101. Atara Biotherapeutics Business Overview
    Table 102. Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 103. Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 104. Atara Biotherapeutics Recent Development
    Table 105. Carina Biotech Company Details
    Table 106. Carina Biotech Business Overview
    Table 107. Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 108. Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 109. Carina Biotech Recent Development
    Table 110. Guangzhou Xiangxue Pharmaceutical Company Details
    Table 111. Guangzhou Xiangxue Pharmaceutical Business Overview
    Table 112. Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product
    Table 113. Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 114. Guangzhou Xiangxue Pharmaceutical Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type: 2020 VS 2027
    Figure 2. Allogeneic CAR T-Cells Features
    Figure 3. Autologous CAR T-Cells Features
    Figure 4. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application: 2020 VS 2027
    Figure 5. Hospital Case Studies
    Figure 6. Diagnostic Center Case Studies
    Figure 7. Others Case Studies
    Figure 8. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Report Years Considered
    Figure 9. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Regions: 2020 VS 2027
    Figure 12. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Regions (2022-2027)
    Figure 13. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Players in 2020
    Figure 14. Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2020
    Figure 16. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
    Figure 17. Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Type (2022-2027)
    Figure 18. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 20. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 21. North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 22. United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 26. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 27. Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 28. Germany Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Region (2016-2027)
    Figure 38. China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 46. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 47. Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 48. Mexico Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 54. Turkey Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Pfizer Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 58. Novartis Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 59. Bristol Myers Squibb Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 60. Legend Biotech Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 61. Sorrento Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 62. CARSGEN Therapeutics，Ltd Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 63. Juno Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 64. Kite Pharma Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 65. Atara Biotherapeutics Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 66. Carina Biotech Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 67. Guangzhou Xiangxue Pharmaceutical Revenue Growth Rate in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Bristol Myers Squibb
Legend Biotech
Sorrento Therapeutics
CARSGEN Therapeutics，Ltd
Juno Therapeutics
Kite Pharma
Atara Biotherapeutics
Carina Biotech
Guangzhou Xiangxue Pharmaceutical
Frequently Asked Questions
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports